| 1 |
Paul Alexander Torrie |
Smith & Nephew |
10 |
| 2 |
Brian Lucas |
Bose |
5 |
| 3 |
Kevin McKernan |
Applied Biosystems |
4 |
| #4 |
Robert Michael Zirin |
GE |
3 |
| #4 |
Donald M. Parker |
Encite |
3 |
| #4 |
Dmitri Menn |
Covidien Lp |
3 |
| #4 |
Yelena Kann |
Radical Plastics |
3 |
| #4 |
James E. Shepard |
Keurig Green Mountain |
3 |
| #4 |
Colin Brenan |
— |
3 |
| #4 |
Jeremy Spaulding |
Osram Sylvania |
3 |
| #11 |
Douglas G. Sabin |
Sage Science |
2 |
| #11 |
Brian Gregory Pierce |
Pfizer |
2 |
| #11 |
John D. Fiegener |
Master Lock Company |
2 |
| #11 |
Barry M. Yomtov |
Heartware |
2 |
| #11 |
Brian J. Chemel |
Digital Lumens Incorporated |
2 |
| #11 |
Seung Cheol Ryu |
Osram Sylvania |
2 |
| #11 |
Andrew J. Bayramian |
Lawrence Livermore National Security |
2 |
| #11 |
Todd C. Zion |
Akston Biosciences |
2 |
| #11 |
Mark Brezinski |
MIT |
2 |
| #11 |
Boris Zuckerman |
HP |
2 |
| #11 |
Alexander Falk |
Altova Gmbh |
2 |
| #22 |
Julian Pelenur |
Bea Systems |
1 |
| #22 |
Carl F. Hitscherich, Jr. |
Biogen Ma |
1 |
| #22 |
Thomas W. Bushman |
Cyberoptics |
1 |
| #22 |
Douglas A. Marsden |
The Procter & Gamble |
1 |
| #22 |
Thomas Mager |
Mahle International Gmbh |
1 |
| #22 |
Naushad K. Variam |
Varian Semiconductor Equipment Associates |
1 |
| #22 |
Paul Sweetnam |
Surface Logix |
1 |
| #22 |
Dhanapalan Nagarathnam |
Synaptic Pharmaceutical |
1 |
| #22 |
Ty Vyn Rock |
Osram Sylvania |
1 |
| #22 |
Bulent Sert |
Separation Technologies |
1 |
| #22 |
Kurt Schmid |
Robert Bosch Gmbh |
1 |
| #22 |
Codanda Chinnappa |
Oracle |
1 |
| #22 |
Christopher Mark Bordne |
GE |
1 |
| #22 |
David B. Joyce |
Crystal Systems |
1 |
| #22 |
John Andrew Sheridan |
Thermo Fisher |
1 |
| #22 |
Harold Boeschenstein |
Irobot |
1 |
| #22 |
Dmitri Menn |
Entegris |
1 |
| #22 |
Peter Finan |
Novartis Ag |
1 |
| #22 |
Kurt Robert Bianculli |
Draeger Medical Systems |
1 |
| #22 |
Sidney Rose |
Rose Displays |
1 |
| #22 |
Jamison Bryce Tuttle |
Pfizer |
1 |
| #22 |
Bradley L. Smith |
Cell Signaling Technology |
1 |